Education
About Us
Working with TipRanks
Follow Us
Bioceres Crop Solutions (BIOX)
NASDAQ:BIOX
Earnings Data
Report Date
Sep 11, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
0.08Last Year’s EPS
-0.03Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 21, 2025
|% Change Since: -0.43%
|Next Earnings Date:Sep 11, 2025
Earnings Call Sentiment|Neutral
Bioceres Crop Solutions experienced significant challenges this quarter, primarily due to the absence of the prior year's Syngenta payments and a slow market in Argentina. However, the company achieved exceptional cash flow performance and received important regulatory approvals for Rinotec, positioning it for future growth. The highlights and lowlights are fairly balanced this quarter.Company Guidance
In the Bioceres Crop Solutions Fiscal Third Quarter 2025 earnings call, several key metrics and achievements were highlighted. Notably, the company reported a $40 million year-over-year improvement in cash flow, which played a significant role in reducing debt and enhancing the cash position. Despite a drop in total revenues to $60.6 million from $84 million the previous year, primarily due to the absence of a $16 million accrual from a Syngenta collaboration, the company maintained a consistent gross margin close to historical levels. The adjusted EBITDA for the quarter was $9 million, down from $21.1 million the previous year, but efforts to streamline the seed business and overall cost structure are expected to yield future savings. The company's strategic focus on enhancing cash generation and capital allocation has been evident, with a notable $23.3 million net cash from operating activities reported, marking a $40.7 million improvement from the previous year. Looking ahead, the launch of Rinotec and further penetration into conventional acreage markets are anticipated to drive future growth.Exceptional Cash Flow Performance
Bioceres reported a $40 million improvement in cash flow year-over-year, helping reduce debt and improve cash position.
Approval of Rinotec
Long-awaited EPA approval of Rinotec, allowing Bioceres to offer a full suite of biological solutions for pest control and plant health globally.
Growth in Seed and Integrated Products
Revenues in seed and integrated products increased by 26%, primarily fueled by accelerated sales of HB4 grain.
Successful Cash Management
Net cash from operating activities reached $23.3 million, a $40.7 million improvement compared to the previous year.
Positive Developments in U.S. and Mexico
U.S. and Mexico markets showed good growth, with early signs of recovery and stabilization in certain areas.
BIOX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BIOX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 21, 2025 | $4.65 | $4.45 | -4.30% |
Feb 11, 2025 | $5.55 | $4.78 | -13.87% |
Nov 12, 2024 | $6.48 | $6.66 | +2.78% |
Sep 09, 2024 | $9.99 | $8.65 | -13.41% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Bioceres Crop Solutions (BIOX) report earnings?
Bioceres Crop Solutions (BIOX) is schdueled to report earning on Sep 11, 2025, TBA Not Confirmed.
What is Bioceres Crop Solutions (BIOX) earnings time?
Bioceres Crop Solutions (BIOX) earnings time is at Sep 11, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BIOX EPS forecast?
BIOX EPS forecast for the fiscal quarter 2025 (Q4) is 0.08.